0002113399-26-000001.txt : 20260414 0002113399-26-000001.hdr.sgml : 20260414 20260414173057 ACCESSION NUMBER: 0002113399-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260414 DATE AS OF CHANGE: 20260414 EFFECTIVENESS DATE: 20260414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allinaire Therapeutics Inc. CENTRAL INDEX KEY: 0002113399 ORGANIZATION NAME: EIN: 810774310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-580441 FILM NUMBER: 26861834 BUSINESS ADDRESS: STREET 1: 11000 CEDAR AVE #18 CITY: CLEVELAND STATE: OH ZIP: 44106 BUSINESS PHONE: 484.367.7303 MAIL ADDRESS: STREET 1: 11000 CEDAR AVE #18 CITY: CLEVELAND STATE: OH ZIP: 44106 D 1 primary_doc.xml X0708 D LIVE 0002113399 Allinaire Therapeutics Inc. 11000 CEDAR AVE #18 CLEVELAND OH OHIO 44106 484.367.7303 DELAWARE Allinaire Therapeutics, LLC None Corporation true Douglas W.P. Hay 11000 Cedar Ave #18 Cleveland OH OHIO 44106 Executive Officer Director Satish Jindal 11000 Cedar Ave #18 Cleveland OH OHIO 44106 Director Samantha Ginther 11000 Cedar Ave #18 Cleveland OH OHIO 44106 Director Arthur Bertelson 11000 Cedar Ave #18 Cleveland OH OHIO 44106 Director Other Decline to Disclose 06b false 2026-01-30 false true false 0 700000 700000 0 false 2 0 0 0 false Allinaire Therapeutics Inc. Douglas W.P. Hay Douglas W.P. Hay CEO 2026-04-14